XML 182 R163.htm IDEA: XBRL DOCUMENT v3.6.0.2
Renasant Corporation (Parent Company Only) Condensed Financial Information (Details 2) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Operating activities                      
Net income $ 23,635 $ 23,179 $ 22,900 $ 21,216 $ 21,160 $ 16,220 $ 15,394 $ 15,240 $ 90,930 $ 68,014 $ 59,582
Adjustments to reconcile net income to net cash provided by operating activities:                      
Gain on sale of securities                 (1,186) (96) (375)
(Increase) decrease in other assets                 13,020 12,705 21,303
Increase in other liabilities                 (16,694) 180 (5,437)
Net cash provided by operating activities                 163,797 252,625 124,683
Investing activities                      
Net cash received in acquisition                 25,263 24,776 0
Net cash used in investing activities                 (351,993) (247,431) (202,802)
Financing activities                      
Cash paid for dividends                 (29,734) (24,557) (21,518)
Excess tax benefits from exercise of stock options                 2,771 537 1,102
Proceeds from issuance of long-term debt                 98,385 40 0
Proceeds from equity offering                 84,105 0 0
Net cash provided by (used in) financing activities                 282,849 44,794 (6,946)
Net increase (decrease) in cash and cash equivalents                 94,653 49,988 (85,065)
Cash and cash equivalents at beginning of year       211,571       161,583 211,571 161,583 246,648
Cash and cash equivalents at end of year 306,224       211,571       306,224 211,571 161,583
Renasant Corporation                      
Operating activities                      
Net income                 90,930 68,014 59,582
Adjustments to reconcile net income to net cash provided by operating activities:                      
Gain on sale of securities                 (1,186) 0 (375)
Equity in undistributed net income of bank subsidiary                 (65,591) (47,428) (40,903)
Amortization/depreciation/accretion                 560 579 385
(Increase) decrease in other assets                 (556) (1,377) 1,345
Increase in other liabilities                 564 1,088 2,591
Net cash provided by operating activities                 24,721 20,876 22,625
Investing activities                      
Purchases of securities held to maturity and available for sale                 (1,380) (2,183) (1,781)
Sales and maturities of securities held to maturity and available for sale                 6,101 1,089 1,142
Investment in subsidiaries                 (75,000) 0 0
Net cash received in acquisition                 0 5,292 0
Other investing activities                 0 0 (64)
Net cash used in investing activities                 (70,279) 4,198 (703)
Financing activities                      
Cash paid for dividends                 (29,734) (24,557) (21,518)
Cash received on exercise of stock-based compensation                 415 102 401
Excess tax benefits from exercise of stock options                 2,771 520 940
Repayments of advances from bank subsidiary                 0 0 (1,500)
Proceeds from issuance of long-term debt                 98,127 0 0
Proceeds from equity offering                 84,105 0 0
Net cash provided by (used in) financing activities                 155,684 (23,935) (21,677)
Net increase (decrease) in cash and cash equivalents                 110,126 1,139 245
Cash and cash equivalents at beginning of year       $ 11,107       $ 9,968 11,107 9,968 9,723
Cash and cash equivalents at end of year $ 121,233       $ 11,107       $ 121,233 $ 11,107 $ 9,968